All Pathways
RadiologyDiagnostic

Incidental Pulmonary Nodule Management (Fleischner 2017)

Incidental Pulmonary Nodule Management (Fleischner 2017): Incidental Pulmonary Nodule on CT → Nodule Morphology? → Solid Nodule Size? → Risk Assessment ...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Incidental Pulmonary Nodule on CT

    Solid or subsolid nodule discovered incidentally

    1. Decision

      Nodule Morphology?

      Solid, part-solid, or pure ground glass

      • Solid nodule
      • Part-solid (GGO with solid component)
      • Pure ground glass (GGO)
      1. Decision

        Solid Nodule Size?

        • <6mm
        • 6-8mm
        • >8mm
        1. Decision

          Risk Assessment (<6mm)

          • Low risk patient
          • High risk patient
          1. End

            No Routine Follow-up

            Optional 12-month CT if high-risk features

          2. End

            Optional 12-Month CT

            Consider follow-up if risk factors present

        2. Action

          6-8mm Follow-up

          Low risk: 6-12mo, then 18-24mo; High risk: same + stability

        3. Action

          >8mm Management

          CT at 3 months, PET/CT, or tissue sampling

      2. Decision

        Part-Solid Size?

        • <6mm
        • ≥6mm solid component
        1. End

          No Routine Follow-up

          Consider 3-6mo CT if suspicious

        2. Action

          3-6 Month CT

          If persistent, PET/CT or biopsy based on solid component

      3. Decision

        Pure GGO Size?

        • <6mm
        • ≥6mm
        1. End

          No Routine Follow-up

        2. End

          CT at 6-12 Months

          Then q2y for 5 years if persistent

Guideline Source

Fleischner Society 2017 Guidelines for Management of Incidental Pulmonary Nodules

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not apply to lung cancer screening populations
  • Does not apply to immunocompromised patients
  • Not for patients with known primary malignancy
  • Age <35 may warrant different approach

Contraindicated Populations

Lung cancer screening patientsKnown malignancy

Applicable Regions

USAUUKEU

AU: Follow ACR/Fleischner approach

UK: BTS guidelines similar but with slight threshold differences

US: Lung-RADS for screening populations differs from Fleischner

Version 1Next review: 2028-01-01

Frequently Asked Questions

What is the Incidental Pulmonary Nodule Management (Fleischner 2017)?

The Incidental Pulmonary Nodule Management (Fleischner 2017) is a diagnostic clinical algorithm for Radiology. It provides a structured decision tree to guide clinical decision-making, based on Fleischner Society 2017 Guidelines for Management of Incidental Pulmonary Nodules.

What guideline is the Incidental Pulmonary Nodule Management (Fleischner 2017) based on?

This algorithm is based on Fleischner Society 2017 Guidelines for Management of Incidental Pulmonary Nodules (DOI: 10.1148/radiol.2017161659).

What are the limitations of the Incidental Pulmonary Nodule Management (Fleischner 2017)?

Known limitations include: Does not apply to lung cancer screening populations; Does not apply to immunocompromised patients; Not for patients with known primary malignancy; Age <35 may warrant different approach. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Incidental Pulmonary Nodule Management (Fleischner 2017) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free